Yanyong Yang

Prof. Dr. Yanyong Yang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
XZXide Zhang
Xide Zhang
LYLiuhuan Yao
Liuhuan Yao
YMYuanyuan Meng
Yuanyuan Meng
BLBailong Li
Bailong Li
YYYanyong Yang
Yanyong Yang
GFGao Fu
Gao Fu
Migrasome is a novel cellular organelle produced during cell migration, and its biogenesis depends on the migration process. It is generated in a variety of cells such as immune cells, metastatic tumor cells, other special functional cells like podocytes and cells in developing organisms. It plays important roles in various fields especially in the information exchange between cells. The discovery of migrasome, as an important supplement to the extracellular vesicle system, provides new mechanisms and targets for comprehending various biological or pathological processes. In this article, we will review the discovery, structure, distribution, detection, biogenesis, and removal of migrasomes and mainly focus on summarizing its biological functions in cell-to-cell communication, homeostatic maintenance, embryonic development and multiple diseases. This review also creates prospects for the possible research directions and clinical applications of migrasomes in the future.

7 February 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JZJian Zhao
Jian Zhao
GYGuanyu Yu
Guanyu Yu
MCMengxi Cai
Mengxi Cai
XLXiao Lei
Xiao Lei
YYYanyong Yang
Yanyong Yang
XZXiao Zhai
Xiao Zhai
Several studies have focused on umbilical cord-derived mesenchymal stem cells (UC-MSCs) due to their potential therapeutic effects in a cluster of diseases. However, there has been no bibliometric analysis evaluating the evolution in UC-MSC research. Therefore, this study aimed to assess scientific activity regarding UC-MSC research. Publications on UC-MSCs were retrieved from the Science Citation Index-Expanded (SCI-E) of the Web of Science (WoS) from 1975 to 2017. Statistical analyses were performed using Excel, GraphPad Prism 5, and VOSviewer software. Comparative analyses were employed to assess contributions between different countries, institutes, and researchers. With 21.26 citations per paper, 1206 papers cited 25,517 times were included. Mainland China contributed the most with 558 papers, with the most citations (6858 times) and the highest H-index (43). South Korea ranked first for number of papers per million people and per trillion gross domestic product (GDP). Keywords were stratified into two clusters by VOSviewer software: cluster 1, “treatments and effects”; and cluster 2, “characteristics”. The average appearing years (AAY) of keywords in cluster 1 was more recent than that in cluster 2. For promising hotspots, “TNF-α” showed the latest AAY at 2014.09, followed by “migration”, “angiogenesis”, and “apoptosis”. We conclude that the number of publications has been continuously growing dramatically since 2002 and that mainland China and South Korea are the most productive regions. The focus gradually shifts from “characteristics” to “treatments and effects”. Attention should be drawn to the latest hotspots, such as “TNF-α”, “migration”, “angiogenesis”, and “apoptosis”. Furthermore, funding agencies might increase investments in exploring the therapeutic potential of UC-MSCs.

13 June 2017 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
KCKun Cao
Kun Cao
XLXiao Lei
Xiao Lei
HLHu Liu
Hu Liu
HZHainan Zhao
Hainan Zhao
JGJiaming Guo
Jiaming Guo
YYYanyong Yang
Yanyong Yang
Radiation‐induced lung injury (RILI) is one of the most common and fatal complications of thoracic radiotherapy. It is characterized with two main features including early radiation pneumonitis and fibrosis in later phase. This study was to investigate the potential radioprotective effects of polydatin (PD), which was shown to exert anti‐inflammation and anti‐oxidative capacities in other diseases. In this study, we demonstrated that PD‐mitigated acute inflammation and late fibrosis caused by irradiation. PD treatment inhibited TGF‐β1‐Smad3 signalling pathway and epithelial–mesenchymal transition. Moreover, radiation‐induced imbalance of Th1/Th2 was also alleviated by PD treatment. Besides its free radical scavenging capacity, PD induced a huge increase of Sirt3 in culture cells and lung tissues. The level of Nrf2 and PGC1α in lung tissues was also elevated. In conclusion, our data showed that PD attenuated radiation‐induced lung injury through inhibiting epithelial–mesenchymal transition and increased the expression of Sirt3, suggesting PD as a novel potential radioprotector for RILI.

5 July 2021 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
LLLei Liu
Lei Liu
YCYuanyuan Chen
Yuanyuan Chen
YHYijuan Huang
Yijuan Huang
KCKun Cao
Kun Cao
TLTingting Liu
Tingting Liu
YYYanyong Yang
Yanyong Yang

1 January 2018 in Vaccine
Verified
Journal Article
Closed access
HZHenghui Zhang
Henghui Zhang
HZHenghui Zhang
Henghui Zhang
YXYongping Xu
Yongping Xu
JYJiansong You
Jiansong You
YYYanyong Yang
Yanyong Yang
XLXiaoyu Li
Xiaoyu Li

1 January 2021 in Journal of Cancer
Verified
Journal Article
Open access
KCKun Cao
Kun Cao
YCYuanyuan Chen
Yuanyuan Chen
SZSongyun Zhao
Songyun Zhao
YHYijuan Huang
Yijuan Huang
TLTingting Liu
Tingting Liu
GFGao Fu
Gao Fu
Objective: Radiotherapy is an indispensable approach for lung cancer, especially for non-small cell lung cancer (NSCLC) with high incidence and mortality. However, cellular resistance to ionizing radiation often results in failure in treatment. In this study, we aimed to investigate the role of Sirt3 in radiotherapy on NSCLC.